A peer-reviewed laboratory study followed the movements of individual G proteins coupled to opioid receptors. Different activating molecules favored different open and closed states, and measurements detected brief intermediate stages. The experiments used purified proteins and controlled molecular assemblies to examine signaling dynamics, rather than measuring pain relief or drug safety in people.
Opioid receptor activation was accompanied by different movements in its G protein signaling partner in one peer-reviewed laboratory study. Full activating molecules favored opening of the protein’s helical domain, while partial activators favored more closed positions. The experiments used purified proteins and controlled molecular assemblies.[1]
Fluorescence energy transfer between labels followed the relative motion of protein regions at the single-molecule level. Measurements detected transient intermediate states between the opening and closing extremes. The researchers followed transitions over time rather than relying on a single fixed structural image. Receptor-bound molecules were compared under different nucleotide conditions.[1]
The protein exchanges guanosine diphosphate, or GDP, for guanosine triphosphate, or GTP, during activation. More closed states favored GDP retention. Comparisons changed when both nucleotides were present rather than testing binding without GDP competition. The study therefore examined movement alongside the molecular environment. Another receptor system supplied a comparison for the dynamic mechanism. The purified-protein experiments did not measure pain relief, respiratory suppression or dependence in people.[1]
